[
  {
    "pmcid": "PMC1199607",
    "outcome": "The mean body weight gain",
    "intervention": "White Grape Juice (WGJ)",
    "comparator": "colored and flavored water (WA)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 50.6,
    "intervention_standard_deviation": null,
    "comparator_mean": -7.0,
    "comparator_standard_deviation": null,
    "notes": "Mean body weight gain reported in grams in Results: 'there was a mean weight gain of 18.3 gm in the AJ fed patients and of 50.6 gm in those given WGJ, whereas there was a mean loss of body weight (- 7.0 gm) among the WA group patients (p = 0.08)'. No SDs reported for weight change by group."
  },
  {
    "pmcid": "PMC1199607",
    "outcome": "The duration of the illness",
    "intervention": "White Grape Juice (WGJ)",
    "comparator": "colored and flavored water (WA)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 47.5,
    "intervention_standard_deviation": 38.9,
    "comparator_mean": 26.5,
    "comparator_standard_deviation": 27.4,
    "notes": "Duration of diarrhea after randomization, in hours, from Table 5: 'The mean +/- SD duration in hours was 49.4 \u00b1 32.6, 47.5 \u00b1 38.9 and 26.5 \u00b1 27.4 in patients fed AJ, WGJ and WA respectively.'"
  },
  {
    "pmcid": "PMC1199607",
    "outcome": "The fecal losses",
    "intervention": "White Grape Juice (WGJ)",
    "comparator": "colored and flavored water (WA)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 3.59,
    "intervention_standard_deviation": 2.35,
    "comparator_mean": 2.19,
    "comparator_standard_deviation": 1.63,
    "notes": "Total fecal losses over the study period in g/kg/h from Table 6: 'The mean \u00b1 SD fecal excretion in g/kg/h was 3.94 \u00b1 2.35, 3.59 \u00b1 2.35, and 2.19 \u00b1 1.63 in AJ, WGJ and WA respectively.' First-day losses are also reported but the overall total is extracted here."
  },
  {
    "pmcid": "PMC2682685",
    "outcome": "Adiponectin in women",
    "intervention": "Red wine",
    "comparator": "Control (water)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 12,
    "comparator_events": null,
    "comparator_group_size": 12,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Only percent change from baseline reported (29.8% increase after red wine in women, P<0.05). Absolute means and SDs for red wine vs water not provided in text or figure."
  },
  {
    "pmcid": "PMC2682685",
    "outcome": "Adiponectin in men",
    "intervention": "Ethanol solution",
    "comparator": "Control (water)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 12,
    "comparator_events": null,
    "comparator_group_size": 12,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Only percent change from baseline reported (17.4% increase after ethanol solution in men, P<0.05). Absolute means and SDs for ethanol vs water not provided in text or figure."
  },
  {
    "pmcid": "PMC2682685",
    "outcome": "Adiponectin in men",
    "intervention": "Beer",
    "comparator": "Control (water)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 12,
    "comparator_events": null,
    "comparator_group_size": 12,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Only percent change from baseline reported (16.1% increase after beer in men, P=0.04). Absolute means and SDs for beer vs water not provided in text or figure."
  },
  {
    "pmcid": null,
    "outcome": "relieving factors in reversible inguinal hernia",
    "intervention": "post-Yoga",
    "comparator": "pre-Yoga",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 19,
    "comparator_events": null,
    "comparator_group_size": 19,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Only medians and ranges reported. Before: median 2 (range 1\u20133); After: median 3 (all 3). Wilcoxon signed-rank z=3.391, P<0.001."
  },
  {
    "pmcid": null,
    "outcome": "effective in the treatment of reversible inguinal hernia",
    "intervention": "post-Yoga",
    "comparator": "pre-Yoga",
    "outcome_type": null,
    "intervention_events": null,
    "intervention_group_size": 19,
    "comparator_events": null,
    "comparator_group_size": 19,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Overall effectiveness is concluded qualitatively from multiple symptom outcomes; no single numeric outcome directly labeled as 'effective in the treatment' is reported."
  },
  {
    "pmcid": null,
    "outcome": "frequency of occurrence in reversible inguinal hernia",
    "intervention": "post-Yoga",
    "comparator": "pre-Yoga",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 19,
    "comparator_events": null,
    "comparator_group_size": 19,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Frequency measured as number of times hernia occurred in last two weeks. Before: median 12 (range 9\u201314, Q1=10, Q3=14, QD=2); After: median 2 (range 0\u20136, Q1=1, Q3=3, QD=1). Wilcoxon signed-rank z=\u22123.835, P<0.001."
  },
  {
    "pmcid": null,
    "outcome": "symptoms of hernia such as heaviness, fullness and pain",
    "intervention": "post-Yoga",
    "comparator": "pre-Yoga",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 19,
    "comparator_events": null,
    "comparator_group_size": 19,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Article states yoga practices are useful in reducing symptoms such as heaviness, fullness and pain, but only pain intensity is quantified. Pain before: median 6 (range 3\u20138, Q1=5, Q3=7, QD=1); after: median 1 (range 0\u20133, Q1=0, Q3=2, QD=1). Wilcoxon signed-rank z=\u22123.864, P<0.001. No separate quantitative data for heaviness or fullness."
  },
  {
    "pmcid": null,
    "outcome": "pain in reversible inguinal hernia",
    "intervention": "post-Yoga",
    "comparator": "pre-Yoga",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 19,
    "comparator_events": null,
    "comparator_group_size": 19,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Pain measured on 0\u201310 numeric rating scale. Before: median 6 (range 3\u20138, Q1=5, Q3=7, QD=1); After: median 1 (range 0\u20133, Q1=0, Q3=2, QD=1). Wilcoxon signed-rank z=\u22123.864, P<0.001. Means and SDs not reported."
  },
  {
    "pmcid": null,
    "outcome": "aggravating factors in reversible inguinal hernia",
    "intervention": "post-Yoga",
    "comparator": "pre-Yoga",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 19,
    "comparator_events": null,
    "comparator_group_size": 19,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Aggravating factors scored as count of present activities (0\u20135) among exercise/walking, bowel movement, bladder activity, lifting, coughing/sneezing. Before: median 4 (range 3\u20135, QD=0.5); After: median 1 (range 0\u20132, QD=0). Wilcoxon signed-rank z=\u22123.875, P<0.001."
  },
  {
    "pmcid": "PMC3580670",
    "outcome": "mean \u00b1 SD length of hospital stay between periods 1 and 2 in patients who did not suffer from VAP",
    "intervention": "Interrupted surveillance, unit A",
    "comparator": "Continuous surveillance, unit B",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": null,
    "comparator_events": null,
    "comparator_group_size": null,
    "intervention_mean": 9.3,
    "intervention_standard_deviation": 11.9,
    "comparator_mean": 11.3,
    "comparator_standard_deviation": 13.0,
    "notes": "Values are mean \u00b1 SD length of hospital stay (days) during period 1 for patients without VAP, reported separately by ICU. Period-2 values (unit A: 9.9 \u00b1 14.8; unit B: 9.1 \u00b1 9.9) are also given in text but no group sizes are reported."
  },
  {
    "pmcid": "PMC3751820",
    "outcome": "improvement in nursing",
    "intervention": "phase I externship program",
    "comparator": "phase II corporate-academic cooperation program",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 19,
    "comparator_events": null,
    "comparator_group_size": 23,
    "intervention_mean": 117.63,
    "intervention_standard_deviation": 19.01,
    "comparator_mean": 158.52,
    "comparator_standard_deviation": 23.19,
    "notes": "Outcome interpreted as post-practicum total nursing competence score (T1). EP group is phase I externship program; CACP group is phase II corporate-academic cooperation program. Values from Table 2."
  },
  {
    "pmcid": null,
    "outcome": "ureteropelvic junction obstruction",
    "intervention": "internal drainage group",
    "comparator": "stentless cases",
    "outcome_type": "binary",
    "intervention_events": 0,
    "intervention_group_size": 30,
    "comparator_events": 1,
    "comparator_group_size": 52,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Recurrence of stenosis requiring reoperation used as proxy for persistent/recurrent ureteropelvic junction obstruction; data from Table 2: 'Recurrence of stenosis reoperation 0 (0) vs 1 (1.9)'."
  },
  {
    "pmcid": null,
    "outcome": "remission rate",
    "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
    "comparator": "treatment as usual (TAU)",
    "outcome_type": "binary",
    "intervention_events": 61,
    "intervention_group_size": 125,
    "comparator_events": 63,
    "comparator_group_size": 133,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Remission defined as BDI-II score \u226413 at 3-month follow-up. Text reports 49% remission in intervention and 47.3% in TAU; event counts calculated as 0.49*125 and 0.473*133 and rounded to nearest whole number."
  },
  {
    "pmcid": null,
    "outcome": "sedative prescriptions",
    "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
    "comparator": "treatment as usual (TAU)",
    "outcome_type": "binary",
    "intervention_events": 52,
    "intervention_group_size": 125,
    "comparator_events": 51,
    "comparator_group_size": 133,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "From Table 2: at 12-month follow-up, 52/125 (42%) in intervention and 51/133 (38%) in TAU had prescriptions for sedatives."
  },
  {
    "pmcid": null,
    "outcome": "sick leave",
    "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
    "comparator": "treatment as usual (TAU)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 125,
    "comparator_events": null,
    "comparator_group_size": 133,
    "intervention_mean": 124.8,
    "intervention_standard_deviation": 102.5,
    "comparator_mean": 123.3,
    "comparator_standard_deviation": 85.0,
    "notes": "From Table 3: mean total duration of sick leave (days) over 0\u201312 months among those with any sick leave. Number of individuals with sick leave: 49 (39%) intervention, 64 (48%) TAU. Group sizes for the trial were 125 and 133, respectively."
  },
  {
    "pmcid": null,
    "outcome": "continued antidepressants until the 6-month",
    "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
    "comparator": "treatment as usual (TAU)",
    "outcome_type": "binary",
    "intervention_events": 86,
    "intervention_group_size": 125,
    "comparator_events": 78,
    "comparator_group_size": 133,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "From abstract and Table 2: at 6-month follow-up, 86/125 (69%) in intervention vs 78/133 (59%) in TAU were on antidepressants."
  },
  {
    "pmcid": null,
    "outcome": "depression severity reduction 12 months",
    "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
    "comparator": "treatment as usual (TAU)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 125,
    "comparator_events": null,
    "comparator_group_size": 133,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Outcome measured with BDI-II. Article reports no significant difference in mean intra-individual change between groups at 12 months, but exact means/SDs are not provided in text or tables."
  },
  {
    "pmcid": null,
    "outcome": "change in quality of life 12 months",
    "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
    "comparator": "treatment as usual (TAU)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 125,
    "comparator_events": null,
    "comparator_group_size": 133,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Outcome measured with EQ-5D. Article states no significant differences in mean intra-individual change between groups at 12 months; exact numeric values not reported."
  },
  {
    "pmcid": null,
    "outcome": "psychological well-being",
    "intervention": "person-centred general practitioners (GP) consultations using MADRS-S",
    "comparator": "treatment as usual (TAU)",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 125,
    "comparator_events": null,
    "comparator_group_size": 133,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Outcome measured with GHQ-12. Figures show trajectories but no exact means/SDs; text reports no significant differences in mean intra-individual change between groups over 12 months."
  },
  {
    "pmcid": null,
    "outcome": "Scores of external regulation",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 0.43,
    "intervention_standard_deviation": 1.04,
    "comparator_mean": 1.19,
    "comparator_standard_deviation": 1.37,
    "notes": "Follow-up at 4 months after intervention; values from Table 3 (Behavioral Regulation in Exercise Questionnaire - external regulation subscale)."
  },
  {
    "pmcid": null,
    "outcome": "Scores of amotivation",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 0.06,
    "intervention_standard_deviation": 0.36,
    "comparator_mean": 0.58,
    "comparator_standard_deviation": 0.92,
    "notes": "Follow-up at 4 months after intervention; values from Table 3 (BREQ-2 amotivation subscale)."
  },
  {
    "pmcid": null,
    "outcome": "Body mass index",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 25.32,
    "intervention_standard_deviation": 3.05,
    "comparator_mean": 26.59,
    "comparator_standard_deviation": 3.53,
    "notes": "Follow-up at 4 months after intervention; values from Table 4 (BMI, kg/m^2)."
  },
  {
    "pmcid": null,
    "outcome": "Sedentary behavior",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 4.26,
    "intervention_standard_deviation": 1.76,
    "comparator_mean": 5.91,
    "comparator_standard_deviation": 2.21,
    "notes": "Sedentary behavior in hours/day at 4\u2011month follow-up; values from Table 3."
  },
  {
    "pmcid": null,
    "outcome": "agility test",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 13.21,
    "intervention_standard_deviation": 1.44,
    "comparator_mean": 13.8,
    "comparator_standard_deviation": 1.14,
    "notes": "9\u00d74 m agility test, time in seconds; follow-up at 4 months after intervention; values from Table 4."
  },
  {
    "pmcid": null,
    "outcome": "Physical activity",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 854.0,
    "intervention_standard_deviation": 271.6,
    "comparator_mean": 470.0,
    "comparator_standard_deviation": 80.46,
    "notes": "Total physical activity in MET\u2011min/week at 4\u2011month follow-up; values from Table 3 (GPAQ)."
  },
  {
    "pmcid": null,
    "outcome": "physical fitness - flexibility",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 35.53,
    "intervention_standard_deviation": 5.87,
    "comparator_mean": 26.83,
    "comparator_standard_deviation": 5.47,
    "notes": "Sit-and-reach flexibility test (cm); follow-up at 4 months after intervention; values from Table 4."
  },
  {
    "pmcid": null,
    "outcome": "physical fitness - muscular endurance",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 17.83,
    "intervention_standard_deviation": 2.7,
    "comparator_mean": 12.48,
    "comparator_standard_deviation": 2.9,
    "notes": "Sit\u2011up test, number of repetitions in 30 seconds; follow-up at 4 months after intervention; values from Table 4."
  },
  {
    "pmcid": null,
    "outcome": "physical fitness - agility",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 13.21,
    "intervention_standard_deviation": 1.44,
    "comparator_mean": 13.8,
    "comparator_standard_deviation": 1.14,
    "notes": "Same 9\u00d74 m agility test as 'agility test' outcome; follow-up at 4 months after intervention; values from Table 4."
  },
  {
    "pmcid": null,
    "outcome": "physical fitness - cardiorespiratory endurance",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 39.1,
    "intervention_standard_deviation": 2.76,
    "comparator_mean": 37.99,
    "comparator_standard_deviation": 2.14,
    "notes": "Maximal oxygen uptake (VO2max, units as reported by Quinn step test formula); follow-up at 4 months after intervention; values from Table 4."
  },
  {
    "pmcid": null,
    "outcome": "Scores of intrinsic motivation",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 13.5,
    "intervention_standard_deviation": 1.79,
    "comparator_mean": 5.51,
    "comparator_standard_deviation": 2.39,
    "notes": "Intrinsic motivation subscale of BREQ\u20112 at 4\u2011month follow-up; values from Table 3."
  },
  {
    "pmcid": null,
    "outcome": "Scores of perception of competence",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 17.2,
    "intervention_standard_deviation": 3.46,
    "comparator_mean": 14.1,
    "comparator_standard_deviation": 3.82,
    "notes": "Perception of competence subscale of Psychological Need Satisfaction in Exercise Scale at 4\u2011month follow-up; values from Table 3."
  },
  {
    "pmcid": null,
    "outcome": "Scores of perception of autonomy",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 30.4,
    "intervention_standard_deviation": 2.83,
    "comparator_mean": 19.85,
    "comparator_standard_deviation": 5.24,
    "notes": "Perception of autonomy subscale of Psychological Need Satisfaction in Exercise Scale at 4\u2011month follow-up; values from Table 3."
  },
  {
    "pmcid": null,
    "outcome": "Scores of enjoyment",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 30.0,
    "intervention_standard_deviation": 3.83,
    "comparator_mean": 24.89,
    "comparator_standard_deviation": 5.2,
    "notes": "Enjoyment motive subscale of MPAM\u2011R at 4\u2011month follow-up; values from Table 3."
  },
  {
    "pmcid": null,
    "outcome": "Scores of health care climate",
    "intervention": "Motivational interviewing through self-determination theory sessions",
    "comparator": "Standard education session",
    "outcome_type": "continuous",
    "intervention_events": null,
    "intervention_group_size": 30,
    "comparator_events": null,
    "comparator_group_size": 30,
    "intervention_mean": 83.1,
    "intervention_standard_deviation": 1.37,
    "comparator_mean": 69.57,
    "comparator_standard_deviation": 1.61,
    "notes": "Health Care Climate Questionnaire total score at 4\u2011month follow-up; values from Table 3."
  },
  {
    "pmcid": null,
    "outcome": "CGI-I response rate (Intervention: fluoxetine, Comparator: placebo)",
    "intervention": "Fluoxetine 20 mg/day",
    "comparator": "Placebo",
    "outcome_type": "binary",
    "intervention_events": 79,
    "intervention_group_size": 101,
    "comparator_events": 62,
    "comparator_group_size": 99,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "CGI-I response defined as CGI-I score \u2264 2 (very much improved or much improved) at week 8; data from Table 2, ITT population."
  },
  {
    "pmcid": null,
    "outcome": "CGI-I response rate (Intervention: desvenlafaxine, Comparator: placebo)",
    "intervention": "Desvenlafaxine 25\u201350 mg/day (weight-based dosing)",
    "comparator": "Placebo",
    "outcome_type": "binary",
    "intervention_events": 68,
    "intervention_group_size": 99,
    "comparator_events": 62,
    "comparator_group_size": 99,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "CGI-I response defined as CGI-I score \u2264 2 (very much improved or much improved) at week 8; data from Table 2, ITT population."
  },
  {
    "pmcid": null,
    "outcome": "Treatment-emergent adverse events (TEAEs) (Intervention: desvenlafaxine, Comparator: placebo)",
    "intervention": "Desvenlafaxine 25\u201350 mg/day (weight-based dosing)",
    "comparator": "Placebo",
    "outcome_type": "binary",
    "intervention_events": 69,
    "intervention_group_size": 115,
    "comparator_events": 79,
    "comparator_group_size": 112,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Any treatment-emergent adverse event during on-therapy period; overall safety population. Percentages reported as 60.0% for desvenlafaxine and 70.5% for placebo."
  },
  {
    "pmcid": null,
    "outcome": "Treatment-emergent adverse events (TEAEs) (Intervention: fluoxetine, Comparator: placebo)",
    "intervention": "Fluoxetine 20 mg/day",
    "comparator": "Placebo",
    "outcome_type": "binary",
    "intervention_events": 72,
    "intervention_group_size": 112,
    "comparator_events": 79,
    "comparator_group_size": 112,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Any treatment-emergent adverse event during on-therapy period; overall safety population. Percentages reported as 64.3% for fluoxetine and 70.5% for placebo."
  },
  {
    "pmcid": null,
    "outcome": "Death or myocardial infarction",
    "intervention": "eptifibatide",
    "comparator": "placebo",
    "outcome_type": "binary",
    "intervention_events": 14.2,
    "intervention_group_size": null,
    "comparator_events": 15.7,
    "comparator_group_size": null,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Values are 30-day CEC-adjudicated event rates (%) for the overall PURSUIT population, taken from Table 5: 'Overall 14.2 15.7 0.042'. Absolute counts and group sizes are not reported in this article."
  },
  {
    "pmcid": null,
    "outcome": "Myocardial infarction",
    "intervention": "eptifibatide",
    "comparator": "placebo",
    "outcome_type": "binary",
    "intervention_events": 12.6,
    "intervention_group_size": null,
    "comparator_events": 13.6,
    "comparator_group_size": null,
    "intervention_mean": null,
    "intervention_standard_deviation": null,
    "comparator_mean": null,
    "comparator_standard_deviation": null,
    "notes": "Values are 30-day CEC-adjudicated MI event rates (%) for the overall PURSUIT population, taken from Table 5: 'Overall 12.6 13.6 0.137'. Absolute counts and group sizes are not reported in this article."
  }
]